MX9710401A - Agente antifungico, compuesto para el mismo, procedimiento para su produccion y metodo para su utilizacion. - Google Patents

Agente antifungico, compuesto para el mismo, procedimiento para su produccion y metodo para su utilizacion.

Info

Publication number
MX9710401A
MX9710401A MX9710401A MX9710401A MX9710401A MX 9710401 A MX9710401 A MX 9710401A MX 9710401 A MX9710401 A MX 9710401A MX 9710401 A MX9710401 A MX 9710401A MX 9710401 A MX9710401 A MX 9710401A
Authority
MX
Mexico
Prior art keywords
producing
same
antifungal agent
compound therefor
dithiolan
Prior art date
Application number
MX9710401A
Other languages
English (en)
Other versions
MXPA97010401A (es
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of MX9710401A publication Critical patent/MX9710401A/es
Publication of MXPA97010401A publication Critical patent/MXPA97010401A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen R-(+)-(E)-[4-(2-clorofenil)-1,3-ditiolan -2-ilideno]-1-imidazolilacetonitrilo, R-(-)-(E)-[4-(2,4-dicloro-fenil)-1,3-ditiolan -2-ilideno] 1--imidazolilacetonitrilo, y sales farmacéuticamente aceptables de ellos que pueden utilizarse como agente farmacéutico. Se describe también un procedimiento para producirlos y un método para tratar micosis utilizándolos.
MXPA/A/1997/010401A 1995-07-08 1997-12-18 Agente antifungico, compuesto para el mismo,procedimiento para su produccion y metodo para suutilizacion MXPA97010401A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
JP7-196174 1995-07-08
JP07/196174 1995-07-08

Publications (2)

Publication Number Publication Date
MX9710401A true MX9710401A (es) 1998-07-31
MXPA97010401A MXPA97010401A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
US5900488A (en) 1999-05-04
NO980055L (no) 1998-03-06
FI980023A (fi) 1998-01-07
IN185384B (es) 2001-01-13
CH692045A5 (de) 2002-01-15
FI980023A0 (fi) 1998-01-07
EP0839035A2 (en) 1998-05-06
KR19990028772A (ko) 1999-04-15
AT407832B (de) 2001-06-25
NZ311796A (en) 1999-06-29
ES2137888B1 (es) 2001-01-01
CN1194582A (zh) 1998-09-30
NO980055D0 (no) 1998-01-06
IL122618A0 (en) 1998-08-16
CA2226214A1 (en) 1997-01-30
AU6319296A (en) 1997-02-10
CA2226214C (en) 2007-04-17
ATA906196A (de) 2000-11-15
FI119357B (fi) 2008-10-31
EP0839035B1 (en) 2002-10-02
HK1009751A1 (en) 1999-06-11
TW450969B (en) 2001-08-21
SE9800016D0 (sv) 1998-01-07
DE19681478B4 (de) 2006-09-21
ZA965745B (en) 1997-01-27
WO1997002821A3 (en) 1997-02-20
DE19681478T1 (de) 1998-07-02
ES2137888A1 (es) 1999-12-16
CN1091596C (zh) 2002-10-02
LU90190B1 (de) 1998-03-02
GB2317615A (en) 1998-04-01
AU697571B2 (en) 1998-10-08
KR100386491B1 (ko) 2003-08-21
GB9726766D0 (en) 1998-02-18
DK176599B1 (da) 2008-10-27
SE9800016L (sv) 1998-01-07
DK1398A (da) 1998-01-07
WO1997002821A2 (en) 1997-01-30
GB2317615B (en) 1998-09-02
IL122618A (en) 2002-07-25

Similar Documents

Publication Publication Date Title
ES2137888A1 (es) Agente antifungico, compuesto para el mismo procedimiento para su produccion y metodo para su utilizacion.
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
WO1992009281A3 (en) Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
TW275584B (es)
HUP9601442A3 (en) Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
AU5785596A (en) A method of supervising the function of a milking machine, a nd a milking machine
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
CA2006267A1 (en) Method of treating herpesviruses
HUP9801409A2 (hu) APO B szekréció és/vagy MTP-gátló hatású tetrahidroizokinolinszármazék, eljárás előállítására és ezt a vegyületet tartalmazó gyógyszerkészítmény
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
DE69624837T2 (de) Mehrschichtiges verpackungsmaterial, verfahren zu dessen herstellung sowie verpackungsbehälter
DE69625996T2 (de) Bauteilbehaelter und verfahren zu dessen herstellung sowie diesen bauteilbehaelter verwendende bauteilzufuhreinrichtung
ITBO930061A1 (it) Metodo e macchina per la realizzazione di pacchetti doppi di sigarette.
BR9304573A (pt) Compostos 2-alcoxi-2-imidazolin-5-onas, processo de preparaçao desses compostos, composiçoes fungicidas e processo de tratamento de culturas contra doenças fúngicas
HK1061843A1 (en) Process for cis-1-(2-(4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronape ethyl) pyrrolidine
AU3113195A (en) Process for preparing 1,3-disubstituted imidazolidinones
DE69803776T2 (de) Fungizide verbindungen, die einen fluorvinyloxyphenyl-rest enthalten und verfahren zu ihrer herstellung
ZA949347B (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production.
BR9811020A (pt) "fungicidas que compreendem 4-metil-6-pentil-2h-piran-2-ona"
AU5288496A (en) 1-{omega-(3,4-dihydro-2-naphthalenyl)alkyl} cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
FR2708610B1 (fr) Dérivés du carboxyméthylidènecycloheptimidazole, méthode pour leur fabrication et agents thérapeutiques les contenant.
GB0021147D0 (en) Chemical process
ITMI922141A1 (it) 5-nitro-metil-imidazolil-3-terbutil-2-idrossiaril-carbinoli, un processo per la loro preparazione e relative composizioni terapeutiche.